Lacey Avery
Impact in
-
- Antibiotic Use and Resistance
-
- Nosocomial Infections in ICU
- Intensive Care Unit Cognitive Disorders
Papers in
-
- Antibiotic Use and Resistance 2
-
- Antimicrobial Resistance in Staphylococcus 1
- Clostridium difficile and Clostridium perfringens research 1
- Co-authors
- John A. Jernigan (3 shared papers)Shelley S. Magill (1 shared paper)Christina B. Felsen (1 shared paper)Lauren Epstein (1 shared paper)Shannon Novosad (1 shared paper)Elizabeth Dufort (1 shared paper)Shelley M. Zansky (1 shared paper)Ghinwa Dumyati (1 shared paper)
- Partner nations
- United States
In The Last Decade
Lacey Avery
3 papers receiving 155 citations
Peers
Comparison fields: 5 of 60
- Applied Microbiology and Biotechnology 25
- Critical Care and Intensive Care Medicine 36
- Molecular Medicine 22
- Clinical Biochemistry 29
- Family Practice 9
Countries citing papers authored by Lacey Avery
This map shows the geographic impact of Lacey Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lacey Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lacey Avery more than expected).
Fields of papers citing papers by Lacey Avery
This network shows the impact of papers produced by Lacey Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lacey Avery. The network helps show where Lacey Avery may publish in the future.
Co-authors
The 24 scholars most cited alongside Lacey Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 107 | |
| 2 | 2016 | 50 | |
| 3 | 2016 | 3 |
About Lacey Avery
Lacey Avery is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, General Health Professions, Epidemiology and Public Health, Environmental and Occupational Health, having authored 3 papers that have together received 160 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (2 papers), Healthcare cost, quality, practices (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Streptococcal Infections and Treatments (1 paper), Sepsis Diagnosis and Treatment (1 paper) and Neonatal and Maternal Infections (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Critical Care and Intensive Care Medicine (36 citations), Molecular Medicine (22 citations), Clinical Biochemistry (29 citations) and Family Practice (9 citations). Lacey Avery has collaborated with scholars based in United States. Frequent co-authors include John A. Jernigan, Shelley S. Magill, Christina B. Felsen, Lauren Epstein, Shannon Novosad, Elizabeth Dufort, Shelley M. Zansky, Ghinwa Dumyati, Raymund Dantes and Jason Lake. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.